The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Drug resistance: Still a daunting challenge to the successful treatment of AML
Open accessAbstract
Resistance to chemotherapy remains a challenging issue for patients and their physicians. P-glycoprotein (Pgp, MDR1, ABCB1), as well as a family of structurally and functionally related proteins, are plasma membrane transporters able to efflux a variety of substrates from the cell cytoplasm, including chemotherapeutic agents. The discovery of ABCB1 made available a potential target for pharmacologic down-regulation of efflux-mediated chemotherapy resistance. In patients with acute myeloid leukemia (AML), a neoplasm characterized by proliferation of poorly differentiated myeloid progenitor cells, leukemic cells often express ABCB1 at high levels, which may lead to the development of resistance to chemotherapy. Thus, AML seemed to be a likely cancer for which the addition of drug efflux inhibitors to the chemotherapeutic regimen would improve outcomes in patients. Despite this rational hypothesis, the majority of clinical trials evaluating this strategy have failed to reach a positive endpoint, most recently the Eastern Cooperative Oncology Group E3999 trial. Here we review data suggesting the importance of ABCB1 in AML, address the failure of clinical trials to support a therapeutic strategy aimed at modulating ABCB1-mediated resistance, and consider the type of research that should be conducted in this field going forward.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., & Gottesman, M. M. (2007) · Science · doi:10.1126/science.1135308 · Cited by 2,416
Self-citationIdentification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513 · cited 1×
“For example, it was demonstrated that LSCs can be generated from committed progenitors retrovirally transduced with either MLL-ENL, MOZ-TIF2 or MLL-AF9 oncogenes, leading to the reacquisition of self-renewal properties and the initiation of AML (Cozzio et al., 2003; Huntly et al., 2004; Krivtsov et al., 2006).”
BackgroundTsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R., & Melamed, M. R. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.9.1974900 · Cited by 1,062
Cancer stem cells: mirage or reality?
Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 979
Chaudhary, P. M., & Roninson, I. B. (1991) · Cell · doi:10.1016/0092-8674(91)90141-k · Cited by 934
Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
Bhatia, M., Wang, J. C. Y., Kapp, U., Bonnet, D., & Dick, J. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5320 · Cited by 850
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Utikal, J., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., & Hochedlinger, K. (2009) · Nature · doi:10.1038/nature08285 · Cited by 836
Genetic variegation of clonal architecture and propagating cells in leukaemia
Anderson, K., Lutz, C., van Delft, F. W., Bateman, C. M., Guo, Y., Colman, S. M., Kempski, H., Moorman, A. V., Titley, I., Swansbury, J., et al. (2011) · Nature · doi:10.1038/nature09650 · Cited by 806
Nuclear reprogramming to a pluripotent state by three approaches
Yamanaka, S., & Blau, H. M. (2010) · Nature · doi:10.1038/nature09229 · Cited by 776
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Huntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
Cozzio, A., Passegué, E., Ayton, P. M., Karsunky, H., Cleary, M. L., & Weissman, I. L. (2003) · Genes & Development · doi:10.1101/gad.1143403 · Cited by 663
Leith, C. P., Kopecky, K. J., Chen, I. M., Eijdems, L., Slovak, M. L., McConnell, T. S., Head, D. R., Weick, J. K., Grever, M. R., Appelbaum, F. R., et al. (1999) · PubMed · doi:10.1182/blood.v94.3.1086.415k32_1086_1099 · Cited by 573
List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Persons, D. L., Slovak, M. L., Dorr, R., Karanes, C., Hynes, H. E., Doroshow, J. H., et al. (2001) · Blood · doi:10.1182/blood.v98.12.3212 · Cited by 419
The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.
Ueda, K., Clark, D. P., Chen, C. J., Roninson, I. B., Gottesman, M. M., & Pastan, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75806-2 · Cited by 388
Self-citationBaer, M. R., George, S. L., Dodge, R. K., O'Loughlin, K. L., Minderman, H., Caligiuri, M. A., Anastasi, J., Powell, B. L., Kolitz, J. E., Schiffer, C. A., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1224.h81602001224_1224_1232 · Cited by 366
Self-citationMDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia
Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O. A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.10.708 · Cited by 355
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
GILLET, J., EFFERTH, T., & REMACLE, J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.002 · Cited by 337
Self-citationA synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
Fung, K. L., & Gottesman, M. M. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.014 · Cited by 335
Self-citationCyclosporin A Is a Broad-Spectrum Multidrug Resistance Modulator
Qadir, M., O'Loughlin, K. L., Fricke, S. M., Williamson, N. A., Greco, W. R., Minderman, H., & Baer, M. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1725 · Cited by 236
Self-citationGreenberg, P. L., Lee, S. J., Advani, R., Tallman, M. S., Sikic, B. I., Letendre, L., Dugan, K., Lum, B., Chin, D. L., Dewald, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.048 · Cited by 235
Cripe, L. D., Uno, H., Paietta, E. M., Litzow, M. R., Ketterling, R. P., Bennett, J. M., Rowe, J. M., Lazarus, H. M., Luger, S., & Tallman, M. S. (2010) · Blood · doi:10.1182/blood-2010-04-277269 · Cited by 233
Shipley, J. L., & Butera, J. N. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.04.002 · Cited by 200
Walter, R. B., Gooley, T. A., van der Velden, V. H. J., Loken, M. R., van Dongen, J. J. M., Flowers, D. A., Bernstein, I. D., & Appelbaum, F. R. (2007) · Blood · doi:10.1182/blood-2006-09-047399 · Cited by 195
Wilson, C. S. (2006) · Blood · doi:10.1182/blood-2004-12-4633 · Cited by 190
Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias
Benderra, Z., Faussat, A.-M., Sayada, L., Perrot, J.-Y., Chaoui, D., Marie, J.-P., & Legrand, O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0795 · Cited by 188
Nakayama, M., Wada, M., Harada, T., Nagayama, J., Kusaba, H., Ohshima, K., Kozuru, M., Komatsu, H., Ueda, R., & Kuwano, M. (1998) · Blood · doi:10.1182/blood.v92.11.4296 · Cited by 172
Bunting, K. D., Zhou, S., Lu, T., & Sorrentino, B. P. (2000) · Blood · doi:10.1182/blood.v96.3.902 · Cited by 168
Chapuy, B., Koch, R., Radunski, U., Corsham, S., Cheong, N., Inagaki, N., Ban, N., Wenzel, D., Reinhardt, D., Zapf, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.103 · Cited by 162
Schaich, M., Soucek, S., Thiede, C., Ehninger, G., Illmer, T., & the SHG AML96 study group (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05319.x · Cited by 161
MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia
Benderra, Z., Faussat, A. M., Sayada, L., Perrot, J., Tang, R., Chaoui, D., Morjani, H., Marzac, C., Marie, J., & Legrand, O. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1895 · Cited by 154
Kolitz, J. E., George, S. L., Dodge, R. K., Hurd, D. D., Powell, B. L., Allen, S. L., Vélez-García, E., Moore, J. O., Shea, T. C., Hoke, E. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.106 · Cited by 150
Kolitz, J. E., George, S. L., Marcucci, G., Vij, R., Powell, B. L., Allen, S. L., DeAngelo, D. J., Shea, T. C., Stock, W., Baer, M. R., et al. (2010) · Blood · doi:10.1182/blood-2009-07-229492 · Cited by 129
Self-citationABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?
Steinbach, D., & Legrand, O. (2007) · Leukemia · doi:10.1038/sj.leu.2404692 · Cited by 127
Damiani, D., Tiribelli, M., Calistri, E., Geromin, A., Chiarvesio, A., Michelutti, A., Cavallin, M., & Fanin, R. (2006) · PubMed · Cited by 125
ABCA3 as a Possible Cause of Drug Resistance in Childhood Acute Myeloid Leukemia
Steinbach, D., Gillet, J., Sauerbrey, A., Gruhn, B., Dawczynski, K., Bertholet, V., de Longueville, F., Zintl, F., Remacle, J., & Efferth, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2587 · Cited by 123
Self-citationLow levels of ABCG2 expression in adult AML blast samples
Abbott, B. L., Colapietro, A.-M., Barnes, Y., Marini, F. C., Andreeff, M., & Sorrentino, B. P. (2002) · Blood · doi:10.1182/blood-2002-01-0271 · Cited by 121
Bram, E. E., Stark, M., Raz, S., & Assaraf, Y. G. (2009) · Neoplasia · doi:10.1593/neo.91314 · Cited by 119
Michieli, M., Damiani, D., Ermacora, A., Masolini, P., Raspadori, D., Visani, G., Scheper, R. J., & Baccarani, M. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01172.x · Cited by 116
Solary, É., Witz, B., Caillot, D., Moreau, P., Desablens, B., Cahn, J.-Y. Y., Sadoun, A., Pignon, B., Berthou, C., Maloisel, F., et al. (1996) · Blood · doi:10.1182/blood.v88.4.1198.bloodjournal8841198 · Cited by 109
Zhou, D.-C., Zittoun, R., & Marie, J. (1995) · PubMed · Cited by 107
van der Kolk, D. M., de Vries, E. G. E., Putten, W. J. V., Verdonck, L. F., Ossenkoppele, G. J., Verhoef, G. E. G., & Vellenga, E. (2000) · PubMed · Cited by 105
Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
van Delft, F. W., Horsley, S. W., Colman, S., Anderson, K., Bateman, C. M., Kempski, H. M., Zuna, J., Eckert, C., Saha, V., Kearney, L., et al. (2011) · Blood · doi:10.1182/blood-2010-10-314674 · Cited by 101
Yin, J. A. L., Wheatley, K., Rees, J. K. H., Burnett, A. K., & Party, T. U. M. A. L. W. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02785.x · Cited by 100
McKenzie, J. L., Takenaka, K., Gan, O. I., et al. (2006) · Blood · doi:10.1182/blood-2006-06-030270 · Cited by 97
Tabe, Y., Konopleva, M. Y., Contractor, R., Munsell, M. F., Schober, W. D., Jin, L., Tsutsumi‐Ishii, Y., Nagaoka, I., Igari, J., & Andreeff, M. (2005) · Blood · doi:10.1182/blood-2004-10-4126 · Cited by 96
Gerrard, G., Payne, E. M., Baker, R. J., Jones, D. T., Potter, M. N., Prentice, H. G., Ethell, M. E., McCullough, H., Burgess, M. A., Mehta, A. B., et al. (2004) · PubMed · Cited by 95
Kornblau, S. M., Estey, E. H., Madden, T. L., Tran, H. T., Zhao, S., Consoli, U., Snell, V., Sanchez‐Williams, G., Kantarjian, H. M., Keating, M. J., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1796 · Cited by 89
Pallis, M., Turzanski, J., Higashi, Y., & Russell, N. H. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290026277 · Cited by 89
Solary, É., Drénou, B., Campos, L., de Crémoux, P., Mugneret, F., Moreau, P., Lioure, B., Falkenrodt, A., Witz, B., Bernard, M., et al. (2003) · Blood · doi:10.1182/blood-2002-11-3419 · Cited by 89
Apáti, Á., Orbán, T. I., Varga, N., Nemeth, A. H., Schamberger, A., Krízsik, V., Erdélyi‐Belle, B., Homolya, L., Várady, G., Padányi, R., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.010 · Cited by 88
Marzac, C., Garrido, E., Tang, R., Fava, F., Hirsch, P., Benedictis, C. D., Corre, E., Lapusan, S., Lallemand, J., Marie, J., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.031823 · Cited by 79
van der Kolk, D. M., de Vries, E., Noordhoek, L., van den Berg, E., van der Pol, M., Müller, M. M., & Vellenga, E. (2001) · Leukemia · doi:10.1038/sj.leu.2402236 · Cited by 79
Wattel, Solary, É., Hecquet, B., Caillot, Ifrah, N., Brion, Mahé, Milpied, N. J., Janvier, Guerci, et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00870.x · Cited by 72
Bates, S. E., Bakke, S., Kang, M. H., Robey, R. W., Zhai, S., Thambi, P. M., Chen, C. C., Patil, S., Smith, T., Steinberg, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0829-03 · Cited by 71
Self-citationPharmacogenetics of ATP-Binding Cassette Transporters and Clinical Implications
Cascorbi, I., & Haenisch, S. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_6 · Cited by 71
Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006–2010
Pulte, D. D., Gondos, Á., & Brenner, H. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp309 · Cited by 65
Methylation-Controlled J Protein Promotes c-Jun Degradation To Prevent ABCB1 Transporter Expression
Hatle, K. M., Neveu, W. A., Dienz, O., Rymarchyk, S., Barrantes, R., Hale, S., Farley, N., Lounsbury, K. M., Bond, J. P., Taatjes, D. J., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01804-06 · Cited by 59
Zhou, S., Zong, Y., Lu, T., & Sorrentino, B. P. (2003) · BioTechniques · doi:10.2144/03356ss04 · Cited by 57
Purification of Hematopoietic Stem Cells Using the Side Population
Lin, K. K., & Goodell, M. A. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)20011-9 · Cited by 56
Lancet, J. E., Baer, M. R., Durán, G. E., List, A. F., Fielding, R. M., Marcelletti, J. F., Multani, P. S., & Sikic, B. I. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.015 · Cited by 54
Self-citationHess, C. J., Errami, A., Berkhof, J. H., Denkers, F., Ossenkoppele, G. J., Nygren, A. O. H., Schuurhuis, G. J., & Waisfisz, Q. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802035990 · Cited by 44
Seedhouse, C., Grundy, M. A., White, P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1484 · Cited by 40
Expression of Functional Markers in Acute Nonlymphoblastic Leukemia
Han, K., Kahng, J., Kim, M., Lim, J., Kim, Y., Cho, B., Kim, H. K., Min, W. S., Kim, C. C., Lee, K. Y., et al. (2000) · Acta Haematologica · doi:10.1159/000046511 · Cited by 37
Damiani, D., Tiribelli, M., Raspadori, D., Michelutti, A., Gozzetti, A., Calistri, E., Candoni, A., Chiarvesio, A., Lenoci, M., Russo, D., et al. (2007) · Hematological Oncology · doi:10.1002/hon.806 · Cited by 36
Do stem-like cells play a role in drug resistance of sarcomas?
Honoki, K. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.184 · Cited by 32
Bacher, U., Haferlach, T., Alpermann, T., Zenger, M., Kröger, N. M., Beelen, D. W., Kern, W., Schnittger, S., & Haferlach, C. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.06.007 · Cited by 23
Cited by
Drug resistance and combating drug resistance in cancer
Wang, X., Zhang, H., & Chen, X. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.10 · Cited by 1,085
Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
Callaghan, R., Luk, F., & Bebawy, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056176 · Cited by 453
ABC transporters as mediators of drug resistance and contributors to cancer cell biology
Fletcher, J. I., Williams, R. T., Henderson, M. J., Norris, M. D., & Haber, M. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.03.001 · Cited by 423
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment: Miniperspective
Waghray, D., & Zhang, Q. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01457 · Cited by 400
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
Begicevic, R.-R., & Falasca, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112362 · Cited by 395
Metadata
- Authors
- Shaffer, B. C., Gillet, J.-P., Patel, C., Baer, M. R., Bates, S. E., & Gottesman, M. M.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 15
- Issue
- 1-2
- Pages
- 62-69
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2086125907
- Cited by
- 259
- References
- 75
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.